ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,592Medicare Part D Prescriptions Filled, Including Refills

Rank: 284 out of 1111

$327K Total Retail Price of All Prescriptions

Rank: 446 out of 1111

204 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
45% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oklahoma
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 204 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

27% of this provider’s 204 patients filled at least one prescription for a schedule three drug, compared to an average of 18%.

Risky Drugs to Seniors

2% of this provider’s 6,602 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$43 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

37 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oklahoma
LISINOPRIL 395 359 1 2
OMEPRAZOLE 311 289 2 4
AMLODIPINE BESYLATE 287 264 3 7
METFORMIN HCL 271 227 4 8
ATORVASTATIN CALCIUM 239 204 5 15
SIMVASTATIN 235 202 6 5
HYDROCODONE-ACETAMINOPHEN 199 179 S3 7 1
LEVOTHYROXINE SODIUM 192 178 8 3
TRAMADOL HCL 185 138 9 13
POTASSIUM CHLORIDE 160 137 10 9
FUROSEMIDE 154 132 11 6
NEXIUM 139 129 12 26
HYDROCHLOROTHIAZIDE 126 108 13 11
GABAPENTIN 123 92 14 10
CLONIDINE HCL 103 69 15 42
TAMSULOSIN HCL 94 94 16 28
PAROXETINE HCL 94 59 16 55
MELOXICAM 93 93 18 18
WARFARIN SODIUM 90 78 19 19
ZOLPIDEM TARTRATE 79 55 20 16
DIGOXIN 75 63 21 47
AZITHROMYCIN 75 68 21 39
ALLOPURINOL 74 51 23 36
GLYBURIDE 73 41 R 24 59
CIPROFLOXACIN HCL 73 66 24 58
METOPROLOL SUCCINATE 72 63 26 20
CARVEDILOL 71 60 27 21
RANITIDINE HCL 71 71 27 29
PROAIR HFA 70 57 29 38
JANUVIA 62 53 30 75
PRAVASTATIN SODIUM 62 62 30 17
LOSARTAN POTASSIUM 61 57 32 34
FLUTICASONE PROPIONATE 60 48 33 27
POLYETHYLENE GLYCOL 3350 59 38 34 45
CYMBALTA 58 47 35 40
VERAPAMIL ER 53 34 36 100
DOXAZOSIN MESYLATE 52 40 37 87
CRESTOR 51 51 38 33
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.